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Background: Behc¸et’s syndrome (BS) is a multisystem immune-related disease of unknown etiology. Recurrent
aphthous stomatitis (RAS) is characterized by the presence of idiopathic oral ulceration without extraoral
manifestation. The interplay between the oral microbial communities and the immune response could play an
important role in the etiology and pathogenesis of both BS and RAS.
Objective: To investigate the salivary and oral mucosal microbial communities in BS and RAS.
Methods: Purified microbial DNA isolated from saliva samples (54 BS, 25 healthy controls [HC], and 8 RAS)
were examined by the human oral microbe identification microarray. Cultivable salivary and oral mucosal mic-
robial communities from ulcer and non-ulcer sites were identified by matrix-assisted laser desorption/ionization
time-of-flight analysis. Mycobacterium spp. were detected in saliva and in ulcer and non-ulcer oral mucosal
brush biopsies following culture on Lowenstein-Jensen slopes and Mycobacterial Growth Indicator Tubes.
Results: There was increased colonization with Rothia denticariosa of the non-ulcer sites of BS and RAS
patients (pB0.05). Ulcer sites in BS were highly colonized with Streptococcus salivarius compared to those of
RAS (pB0.05), and with Streptococcus sanguinis compared to HC (pB0.0001). Oral mucosa of HC were
more highly colonized with Neisseria and Veillonella compared to all studied groups (pB0.0001).
Conclusions: Despite the uncertainty whether the reported differences in the oral mucosal microbial community
of BS and RAS are of causative or reactive nature, it is envisaged that restoring the balance of the oral microbial
community of the ulcer sites may be used in the future as a new treatment modality for oral ulceration.
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T
he role of oral microbiota and gut commensals
in the pathogenesis of immune-related diseases
has been highlighted in autoimmune encepha-
lomyelitis, rheumatoid arthritis, pancreatic diseases, and
inflammatory bowel disease (16). Furthermore, oral toler-
ization and probiotic therapy have been suggested as
treatment modalities with potential benefits (79).
BS is a multisystemic immune-related disease chara-
cterized by recurrent oral ulceration presenting as the
initial clinical sign of the disease in more than 80% of the
cases (10). Because of this observation, it is thought that
the oral environment may play a very significant role in
the etiology and pathogenesis of BS. To date, the con-
sensus is that the disease is triggered by an intense in-
flammatory response to an undefined environmental factor
in a genetically susceptible host but, as yet, the etiology
remains poorly understood (11, 12).
A bacterial etiology was suggested in the literature and
the uncommon serovars of Streptococcus sanguinis KTH-
1 and KTH-3 (later reclassified as S. oralis) were thought
to be a potential etiological factor in BS based on
their frequent isolation from this group of patients.
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Furthermore, BS showed marked skin reactivation to
streptococcal antigens, and lymphoproliferative responses
were observed against KTH-1 and KTH-3 whole cell
antigen (1315).
The cross-reactivity of bacterial heat shock proteins
(HSP) with their mammalian counterparts was also
studied in relation to BS (13). The serum antibody titer
and delayed-type hypersensitivity against streptococcal
antigens were reported as significantly higher in BS than
in controls (16, 17). Indeed, oral tolerization with the
peptide (336351) of Heat Shock Protein 60 (HSP60) was
investigated in a Phase I/II clinical trial with promising
results (9).
In a recent study, Staphylococcus aureus, Moraxella,
and Streptococcus were found to colonize the conjunctiva
of BS (18). Likewise, S. aureus and Prevotella were more
commonly isolated from the skin lesions of BS (19).
Furthermore, one of the studies illustrated that treat-
ment with azithromycin decreased folliculitic lesions and
accelerated the healing of oral ulcers (20). In another
study, minocycline successfully reduced the frequency of
clinical symptoms in BS and indeed reduced the in vitro
production of the pro-inflammatory cytokines by their
peripheral blood mononuclear cells when stimulated with
streptococcal antigen (16). Moreover, in a pilot study,
probiotic treatment in the form of Lactobacillus brevis
CD2 lozenges seemed to be beneficial in controlling the
oral ulceration of BS (7).
To date, the oral microbial profile of BS has not been
fully identified. This study aimed to fill that gap by in-
vestigating the oral mucosal and salivary microbial com-
munity of BS and comparing it to HC. Furthermore, the
oral microbial profile of BS during orally active and
inactive phases of the disease and in ulcer sites compared
to non-ulcer sites in the same patients was studied. To
investigate the specificity of any observed disturbance in
the salivary and oral mucosal microbial community in BS,
we investigated RAS as a disease control. RAS is a com-
mon oral mucosal disease causing idiopathic recurrent
oral ulceration without extra-oral manifestation. Bacterial
etiology was suggested in the past but never proven.
Recently, the disturbance in the oral mucosal community
in RAS was reported with Prevotella more frequently
colonizing the ulcerative mucosa, while Bacteroidales
colonized the non-ulcer sites more frequently (2123).
Materials and methods
Subjects and samples
The patient cohort was recruited from the Royal London
Hospital and St. Thomas’ Hospital, London, UK, after
ethical approval was granted. BS was classified according
to the International Study Group (ISG) criteria (24) and
divided into two groups: orally active and orally in-
active. The BS patient exclusion criteria were as follows:
1) not fulfilling the ISG criteria, 2) pregnancy, 3) age
under 18, and 4) treatment with systemic or topical
antibacterial agents during the 6 weeks preceding sample
collection. The HC exclusion criteria were as follows:
1) chronic systemic disease, 2) regular medications, 3)
pregnancy, 4) age under 18, 5) history of recurrent oral
ulceration, and 6) treatment with systemic or topical
antibacterial agents during the 6 weeks preceding sample
collection. RAS exclusion criteria were similar to HC,
but they had a history of recurrent oral ulceration of
indefinable cause and no other systemic manifestation.
Eighty-seven subjects were included in this study:
54 BS (F/M,1 35/19; mean age, 41.67912.16), 25 HC
(F/M, 15/10; mean age, 38912.27), and 8 RAS (F/M,
5/3; mean age, 43.50910.00). Out of the 54 BS patients,
19 (F/M, 11/8) were orally active, having oral ulcers,
during the time of sampling and 35 (F/M, 24/11) were
orally inactive, and had no oral ulcers. Twelve subjects
gave consent only for sample collection; therefore, clinical
assessment was performed on a total of 65 individuals
(54 BS, 15 HC, and 6 RAS). Unstimulated saliva samples
(1 ml) were collected from all subjects. Oral mucosal
swabs (Amies liquid transport medium swabs; Copan Diag-
nostics, Inc., Murrieta, CA, USA) and brush biopsies
(Flowgen, Nottingham, UK) (25) were collected from
ulcer and non-ulcer sites, after a sterile water rinse,
from 10 orally active BS patients, 10 orally inactive BS
patients, 10 HC volunteers, and 6 RAS patients (50% of
RAS were orally active at time of sample collection).
Oral health status
The oral health status was studied for all participants who
gave consent for both the clinical assessment and sample
collection (54 BS, 15 HC, and 6 RAS). The following oral
health status indices were investigated: decayed, missing,
and filled teeth (DMFT) index, plaque index (PI), gingi-
val index (GI), sulcus bleeding index (SBI), periodontal
pocket depth (PPD), and attachment loss (AL) (2629).
To standardize the clinical assessment, the same qualified
examiner performed all measurements for all subjects
enrolled in this study.
Human oral microbe identification microarray
(HOMIM) analysis
HOMIM analysis allows for the simultaneous detection
of 397 of the most prevalent oral bacterial species,
including uncultivable oral bacteria (30).
Microbial DNA was isolated from 87 saliva samples
from 35 orally inactive BS, 19 orally active BS, 25 HC, and
8 RAS using the ArchivePure DNA isolation kit (5 Prime,
Nottingham, UK), following the manufacturer’s instruc-
tions. DNA samples were checked for the presence and
quality of DNA using a NanoDrop spectrophotometer
1F/M, female/male.
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(Labtec, East Sussex, Uckfield, UK). Samples were then
checked for the presence of bacterial DNA by using gen-
eral bacterial primers for the 16S rDNA gene (forward:
GATTAGATACCCTGGTAGTCCAC and reverse: CCC
GGGAACGTATTCACCG). The samples were stored
at 808C until HOMIM analysis, which was performed
according to the previously published protocol (30).
Matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) analysis
Eighty-five samples (49 oral swabs from ulcerated and
non-ulcerated oral mucosa and 36 unstimulated saliva
samples) from 10 orally active BS patients, 10 orally in-
active BS patients, 10 HC volunteers, and 6 RAS patients
(50% orally active) from the above-mentioned cohorts
were collected. The samples (saliva samples and swabs in
liquid Amies transport media) were diluted in sterile saline
at 102 and 104 and cultured on seven different culture
media: blood agar, chocolate agar, colistin nalidixic acid
agar, MacConkey agar, gonococcus agar, Sabouraud agar,
and fastidious anaerobe agar. Blood agar, chocolate agar,
and gonococcus agar plates were incubated at 378C for
48 hours in a CO2 enriched environment. Colistin nalidixic
acid agar, MacConkey agar, and Sabouraud agar plates
were incubated at 378C for 48 hours in an O2-enriched
environment. The fastidious anaerobe agar plates were
incubated at 378C for 7 days in an anaerobic environment.
Bacteria grown on blood agar plates were quantified as
colony forming units. Isolated colonies were recultured in
the same culture environments for homogeneity. Peptides
were isolated by the acetonitrile precipitation method ac-
cording to the manufacturer’s instructions (Bruker Daltonics,
Bremen, Germany). The different peptides isolated from
each bacteria were analyzed by MALDI-TOF using the
MALDI Biotyper. The analysis was conducted in a
96-target plate by applying 1 ml of each peptide sample
to a different target, followed by 1 ml of the crystallized
molecules in the MALDI matrix (Bruker Daltonics, Bremen,
Germany) to protect the peptides and help in the laser
beam ionization process.
MALDI-TOF applied nitrogen pulsed laser ionization
to the peptide samples to ionize and separate them based
on their mass/charge ratio. The resulting spectra formula-
ted the protein fingerprint (2,00020,000 Dalton range),
which was then compared to a database of known spectra
to identify and type the bacterial species. A score of 1.7
or above was considered a reliable identification of the
investigated microorganism.
Mycobacterial analysis
A total of 85 samples (49 oral mucosal brush biopsies
from ulcerated and non-ulcerated oral mucosa and 36
samples of unstimulated saliva) were collected from the
same cohort for mycobacterial analysis. All brush bio-
psy samples were decontaminated using 3% oxalic acid,
whereas all saliva samples were treated with 2% sodium
hydroxide and N-acetyl-L-cysteine.
All samples were cultured on Lowenstein-Jensen slopes
and in Mycobacterial Growth Indicator Tubes (MGIT) fol-
lowing the manufacturer’s instructions (Becton Dickinson
Diagnostic Instrument Systems, NJ, USA). MGIT tubes
were incubated in the MGIT 960 system (Becton Dickinson,
Sparks, MD, USA). All samples were incubated for
6 weeks.
Identification of putative Mycobacterium isolates was
accomplished by polymerase chain reaction (PCR) and
DNA line probe hybridization assays by using the Geno-
Type Mycobacterium CM kit following the manufacturer’s
instructions (Hain Lifescience, Nehren, Germany).
Statistical analyses
GraphPad Prism† statistical package was used in the data
analysis (GraphPad Software Inc., San Diego, CA, USA).
Mean, median, minimum, maximum, range, standard
deviation, standard error of the mean, and percentages
were used to describe the data. The data were analyzed
by MannWhitney U test when comparing quantitative
data of two groups, and by KruskalWallis test when com-
paring quantitative data of more than two groups. For the
purpose of comparing the frequency of single microor-
ganism colonization between the different groups, Fisher’s
exact test was employed. Non-parametric multivariate
analysis of variance (MANOVA) with Bonferroni post-
tests was also used when comparing multiple variants
in relation to different groups. For the purpose of
correspondence analysis, MeV (Multiexperiment Viewer)
statistical pack was employed (Dana-Farber Cancer
Institute, Boston, MA, USA). A pB0.05 was considered
statistically significant. However, for the purpose of the
concordance analysis, the p-value was adjusted using the
BenjaminiHochberg correction.
Results
BS patients have less favorable oral health
status compared to HC
BS showed a statistically higher DMFT score compared
to the HC, but there was no statistically significant dif-
ference between BS and RAS (p0.0162 and p0.9585,
respectively).
The same pattern was observed in relation to GI, SBI,
PPD, and AL (Fig. 1).
Salivary microbial community analysis by
HOMIM analysis
The positive identification for target probes in the four
investigated groups are illustrated in Fig. 2a. Correspon-
dence analysis using BenjaminiHochberg correction
did not show any apparent clustering of the investigated
groups (Supplementary Table 1). However, analyzing the
Oral microbiota of BS and RAS
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different bacterial species using MANOVA showed that
saliva from orally active BS was significantly colonized
with Bifidobacterium dentium and Prevotella histicola. At
the same time, orally active BS saliva was less frequently
colonized with Campylobacter concisus, Clostridiales spp.,
Fusobacterium periodonticum, Gemella sanguinis, Neisseria
spp., and Oribacterium sinus (Fig. 2b).
MALDI-TOF analysis of cultivable salivary and oral
mucosal microbial community
MALDI-TOF analysis of 85 samples led to isolation,
purification, and identification of 905 microorganisms.
From these 85 samples, 60 different oral bacterial species,
and five species of fungi were identified (Supplementary
Fig. 1). Figure 3a through c illustrates the difference in
the oral mucosal and salivary microbial load in the four
investigated groups.
Cultivable salivary microbial analysis
The cultivable salivary microbial community showed great
variability between individuals in each group and also
between individuals in different groups. Neisseria was
isolated more frequently from HC in comparison to orally
active BS and orally inactive BS (100 vs. 66.7%, pB0.0001
and 100 vs. 63.6%, pB0.0001, respectively), whereas
Staphylococcus showed higher representation in the orally
active BS saliva (55.6 vs. 33%, p0.0002). There was an
increase in the levels of salivary S. sanguinis in orally
active BS (44.4%) compared to orally inactive BS (9.1%,
pB0.0001), RAS (0%, pB0.0001), and HC (20%,
pB0.0001). Candida albicans was statistically significantly
more frequently isolated from the saliva of orally inactive
BS compared to HC and RAS (pB0.05).
Imbalance in the cultivable oral mucosal
microbial community in orally active BS
Neisseria and Veillonella were isolated more frequently
from HC in comparison to the non-ulcerated and ulcer-
ated mucosa of orally active BS (88.9 vs. 75%, p0.0159
and 22.2 vs. 12.5%, pB0.0001, respectively) and (88.9 vs.
63%, pB0.0001, and 22.2 vs. 13%, pB0.0001, respec-
tively). Rothia spp. showed higher representation in the
non-ulcerated mucosa of orally active BS (87.5 vs. 44.4%,
pB0.0001). In particular, Rothia dentocariosa was more
frequently isolated from the non-ulcerated mucosa of
orally active BS in comparison to the ulcerated mucosa of
orally active BS, ulcerated mucosa of RAS, and the oral
mucosa of HC (pB0.05).
Rothia also showed higher representation in the ulce-
rated mucosa of orally active BS in comparison to HC
(75 vs. 44.4%, p0.0069). However, Rothia dentocariosa
BS (n=54) HC (n=15) RAS (n=6)
Indices p value Mean SD Mean SD Mean SD
DMFT p=0.0162 9.18* 7.31 4.81* 7.56 8.83 4.54
PI p=0.2756 0.93 0.78 0.52 0.52 0.56 0.84
GI p=0.0056 1.17* 0.59 0.81* 0.42 1.18 0.40
SBI p=0.0002 1.01* 0.55 0.27* 0.46 0.67 0.52
PPD p=0.03 87 1.99* 0.43 1.58* 0.36 1.98 0.05
AL p=0.01 45 2.79* 0.75 1.79* 0.66 2.26 0.30
AL:Attachment Level; BS: Behçet’s Syndrome; DMFT: Decayed; 
Missing, Filled Teeth Index; GI: Gingival Index; HC: Healthy Controls; 
n: number; PI: Plaque Index; PPD: Periodontal Probing Depth; RAS: 
Recurrent Aphthous Stomatitis; SBI: Sulcus Bleeding Index; SD:
Standard Deviation.
P value is corresponding to the pair of *value in the same raw.
Oral health status
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Fig. 1. Oral health status of participants with Behc¸et’s syndrome (BS) in comparison to those with recurrent aphthous
stomatitis (RAS) and healthy controls (HC). There is a statistically significant difference between BS and HC in all the
investigated indices except the plaque index.
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was statistically significantly less likely to colonize the ul-
cerated mucosa of orally active BS compared to the non-
ulcerated mucosa of orally active BS (pB0.05). There was
a noticeable shift toward Rothia mucilaginosa (50%), as it
was isolated more frequently than Rothia denticariosa
(37.5%) from the ulcer sites of orally active BS (Fig. 4).
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Fig. 2. Salivary microbial community analysis by human oral microbe identification microarray. (a) The average number of hits
per sample for the salivary microbial community. There is no statistically significant difference in the number of hits per sample
among all the investigated groups. (b) Multivariate analysis of variance showed imbalance in the salivary microbial community
of orally active BS in comparison to HC.
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Interestingly, colonization of the ulcerative mucosa of BS
with S. salivarius was statistically significantly higher
than in the ulcerative mucosa of RAS (pB0.05).
There was an observed increase in the colonization
of orally active BS ulcerated oral mucosa sites with S.
sanguinis as compared to HC oral mucosa (25 vs. 0%,
pB0.0001). Ten different Streptococcus species were iso-
lated from the non-ulcerated oral mucosa of BS patients,
and eight from their ulcerated oral mucosa. On the
other hand, only five different Streptococcus species were
isolated from the oral mucosa of HC, and six from the
oral mucosa of RAS.
Cultivable oral mucosal community in inactive BS
In concordance with the previous observation, Neisseria
and Veillonella were isolated more frequently from HC
(88.9 vs. 44.4%, p0.0009 and 22.2 vs. 0%, pB0.0001,
respectively), whereas Rothia showed higher representa-
tion in the oral mucosa of orally inactive BS (77.8 vs.
44.4%, pB0.0001).
Cultivable oral mucosal community in RAS
Similar to the pattern observed in BS oral mucosa, Rothia
dentocariosa was isolated more frequently from the non-
ulcerated mucosa of RAS in comparison to the ulcerative
mucosa of RAS (pB0.05). Likewise, Streptococcus mitis
was statistically significantly more likely to colonize the
non-ulcerated mucosa of RAS in comparison to ulcerative
mucosa of RAS (pB0.05). Similar to the pattern observed
in the oral ulcer sites of BS, Neisseria and Veillonella were
isolated more frequently from HC in comparison to RAS
(88.9 vs. 25%, pB0.0001 and 22.2 vs. 0%, pB0.0001,
(b) Oral Mucosal Microbial Load in Orally Active BS
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Fig. 3. The oral mucosal and salivary microbial load of orally active BS, orally inactive BS, RAS, and healthy controls (HC). (a)
There is no statistically significant difference in the oral mucosal microbial load between the four investigated groups (p0.2283).
(b) There is no statistically significant difference in the oral mucosal load colonizing both ulcerated and non-ulcerated oral
mucosa of orally active BS (p0.4595). (c) There is a statistically significant decrease in the salivary microbial load of the orally
inactive BS in comparison to HC (p0.0185).
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respectively), whereas Rothia showed slightly higher re-
presentation in the oral mucosa of RAS (50 vs. 44.4%,
p0.0564).
Mycobacterial analysis
Two different species of non-tuberculosis mycobacteria
(Mycobacterium gordonae and Mycobacterium chelonae)
were isolated from four orally active BS saliva samples.
Mycobacterium avium intracellulare was isolated from one
orally inactive BS saliva. There was no Mycobacterium
isolated from any of the brush biopsies of orally active and
orally inactive BS. Mycobacterium gordonae and Mycobac-
terium kansasii were isolated from two HC saliva samples.
Mycobacterium gordonae was isolated from one orally
inactive RAS saliva sample.
Discussion
It is estimated that the human oral cavity is colonized by
approximately 700 different major bacterial species, which
produce a huge number of different pathogen associated
molecular pattern peptides and polysaccharides that can
interact with each other and the host immune system to
maintain a stable symbiotic microenvironment during
health (31, 32). If this balance is disturbed, the symbio-
tic relationship will shift to allow colonization or over-
growth of potentially pathogenic species, inducing a
pathogenic process leading to various disease symptoms
(5, 6, 3339).
It is well documented that the human microbial com-
munity includes a ‘core’ set of organisms that are com-
mon among most individuals and a ‘variable’ community
that evolves in response to lifestyle and phenotypic and
genotypic differences (32, 40). The bacterial genera and
species that dominate the mouth vary considerably be-
tween healthy individuals. However, in general the healthy
human mouth is inhabited by nine main bacterial phyla
(Firmicutes, Proteobacteria, Bacteroidetes, Actinobacteria,
Fusobacteria, TM7, Spirochaetes, and Synergistes) (41).
On the genus level, Streptococcus is known to be the most
abundant genus, followed by Haemophilus, Neisseria,
Prevotella, Veillonella, and Rothia.
Recent studies have indicated that the oral microbial
community changes considerably during certain chronic
diseases, such as pancreatic and inflammatory bowel dis-
ease, with the potential for using the salivary microbiome
as useful, non-invasive biomarkers (5, 6). In addition, there
is evidence demonstrating the impact of HIV infection and
treatment with antiretroviral medication on the commu-
nity organization of the oral microorganisms (34).
This study is the first in-depth investigation of the oral
and salivary microbial community of BS. However, there
is some evidence in the literature indicating an increase in
the Streptococcus load and the existence of an unfavor-
able shift in the cutaneous and conjunctival microflora in
BS (13, 18, 19, 42). We have observed an imbalance in the
oral mucosal and salivary microbial community in orally
active BS. Members of the phylum Actinobacteria, espe-
cially the genus Rothia, were represented more frequently
on the oral mucosa of BS and RAS, as compared to HC
volunteers. On the other hand, Neisseria and Veillonella
were more often represented in HC oral mucosa. Further-
more, the ulcer sites of orally active BS and RAS seemed
to be less able to support the growth and multiplication
of Rothia dentocariosa.
Fig. 4. Rothia in ulcer sites of orally active BS. The proportion of Rothia denticariosa in relation to the other species of Rothia
was less than that seen in the non-ulcerated sites. Data presented as percentage.
Oral microbiota of BS and RAS
Citation: Journal of Oral Microbiology 2015, 7: 27150 - http://dx.doi.org/10.3402/jom.v7.27150 7
(page number not for citation purpose)
Interestingly, the ulcer sites of BS seemed to be colo-
nized with Streptococcus more frequently than the ulcer
sites of RAS. In addition, the complexity of the Strepto-
coccus community was enhanced in the oral mucosa of BS
patients in general. As noted in another published study
investigating the bacterial diversity in aphthous ulcers,
Prevotella was isolated more frequently in the saliva of BS
who had active oral ulcerations at the time of sampling (23).
There was also increased salivary C. albicans in BS
patients. However, topical and/or systemic steroid treat-
ment was used in 68% of BS patients, who had C. albicans
isolated from their saliva at the time of the sampling
(p0.0038). Steroid treatment is a known risk factor for
oral mucosal colonization and infection with Candida
spp. There is evidence in the literature indicating that the
topical and systemic application of corticosteroid can
decrease total salivary IgA. This factor would favor an
increase in C. albicans colonization in a patient cohort
that is frequently treated with topical and systemic corti-
costeroid preparations (68%) (43).
Despite the uncertainty as to whether the reported
differences in the oral mucosal microbial balance of BS
and RAS are of causative or reactive nature, re-establishing
these differences might prove to be important in promot-
ing rapid recovery from oral ulceration. We envisage that
restoring the balance of the oral microbial community of
the ulcer sites by patient-specific personalized probiotic
therapy may be employed in the future as a treatment
modality for oral ulceration.
Key message
1. The ulcer sites of orally active BS and RAS seemed
to be less able to support the growth and multi-
plication of Rothia dentocariosa.
2. Neisseria and Veillonella were more represented in
HC oral mucosa.
3. It is predicted that restoring the balance of the micro-
bial community may prove to be of great importance
in promoting rapid recovery from oral ulcerations.
4. Mycobacteria do not appear to be significant in BS
and RAS.
Limitations of the study
The number of patients investigated in the cultivable assays
was small because of the technical nature of these assays,
which does not allow large sample size. HOMIM was not
possible on swab and brush biopsies samples isolated from
the ulcer and non-ulcer sites due to the low DNA quantity
achieved from these types of samples.
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